Loading...
Header Logo
Keywords
Last Name
Institution

Francesco Massari

Concepts (125)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
5
2018
40
0.910
Why?
Kidney Neoplasms
5
2018
69
0.890
Why?
Stents
4
2015
221
0.570
Why?
Spinal Fractures
5
2009
42
0.500
Why?
Aneurysm, Dissecting
3
2015
62
0.490
Why?
Intracranial Aneurysm
3
2015
95
0.480
Why?
Protein Kinase Inhibitors
4
2017
75
0.430
Why?
Neoplasm Recurrence, Local
3
2016
138
0.360
Why?
Middle Cerebral Artery
2
2015
24
0.340
Why?
Subarachnoid Hemorrhage
2
2015
34
0.340
Why?
Vertebroplasty
3
2009
7
0.330
Why?
Treatment Outcome
15
2018
2569
0.320
Why?
Embolization, Therapeutic
2
2015
100
0.320
Why?
Retrospective Studies
11
2018
2449
0.260
Why?
Aged
16
2018
7523
0.250
Why?
Italy
6
2018
39
0.240
Why?
Aged, 80 and over
11
2018
2814
0.230
Why?
Back Pain
3
2008
23
0.220
Why?
Middle Aged
16
2018
9747
0.220
Why?
Antineoplastic Agents
3
2017
319
0.220
Why?
Anilides
1
2018
7
0.210
Why?
Bone Cements
3
2008
17
0.200
Why?
Pyridines
1
2018
83
0.200
Why?
Male
18
2018
17016
0.200
Why?
DNA Mutational Analysis
1
2017
141
0.190
Why?
Blood Vessel Prosthesis
1
2015
75
0.170
Why?
Dimethyl Sulfoxide
1
2015
16
0.170
Why?
Polyvinyls
1
2015
16
0.170
Why?
Osteoporosis
4
2009
114
0.170
Why?
Androstenes
1
2014
1
0.170
Why?
Nephrectomy
1
2014
35
0.170
Why?
Cerebellum
1
2015
77
0.170
Why?
Cerebral Angiography
4
2015
98
0.160
Why?
Polymethyl Methacrylate
4
2008
14
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
147
0.150
Why?
Female
15
2018
18522
0.150
Why?
Protein-Tyrosine Kinases
1
2014
137
0.150
Why?
Follow-Up Studies
5
2015
1512
0.150
Why?
Pancreatic Neoplasms
1
2014
194
0.140
Why?
Graft Occlusion, Vascular
1
2012
59
0.140
Why?
Multiple Myeloma
3
2008
78
0.140
Why?
Humans
18
2018
33675
0.140
Why?
Adult
8
2018
9529
0.130
Why?
Cardiomyopathy, Dilated
1
2011
17
0.130
Why?
Heart-Assist Devices
1
2011
40
0.120
Why?
Pain Measurement
2
2008
185
0.120
Why?
Mutation
1
2017
1743
0.120
Why?
Stroke Volume
1
2011
189
0.120
Why?
Fractures, Compression
1
2009
6
0.120
Why?
Spinal Neoplasms
1
2008
13
0.110
Why?
Spine
1
2008
39
0.110
Why?
Quality of Life
1
2011
451
0.100
Why?
Stroke
1
2012
509
0.090
Why?
Spinal Diseases
1
2006
14
0.090
Why?
Spinal Cord Compression
1
2005
12
0.090
Why?
Fractures, Spontaneous
1
2005
10
0.090
Why?
Magnetic Resonance Imaging
3
2006
993
0.090
Why?
Radiology, Interventional
1
2005
22
0.090
Why?
Fracture Fixation, Internal
1
2005
33
0.090
Why?
Disease Progression
2
2018
472
0.090
Why?
Orthopedic Procedures
1
2005
34
0.090
Why?
Longitudinal Studies
3
2015
707
0.090
Why?
Patient Selection
3
2017
291
0.080
Why?
Survival Analysis
2
2018
372
0.080
Why?
Magnetic Resonance Angiography
2
2015
96
0.080
Why?
Proportional Hazards Models
2
2016
465
0.070
Why?
Survival Rate
2
2014
470
0.070
Why?
Prognosis
2
2015
875
0.070
Why?
Tomography, X-Ray Computed
3
2012
864
0.060
Why?
Administration, Oral
1
2018
201
0.050
Why?
Time Factors
2
2016
2591
0.050
Why?
Lumbar Vertebrae
2
2008
64
0.050
Why?
Chemotherapy, Adjuvant
1
2016
60
0.050
Why?
Disease-Free Survival
1
2016
108
0.050
Why?
Dose-Response Relationship, Drug
1
2018
698
0.050
Why?
Prosthesis Design
1
2015
80
0.040
Why?
Equipment Failure Analysis
1
2015
65
0.040
Why?
Fluoroscopy
2
2006
43
0.040
Why?
Postoperative Complications
2
2011
583
0.040
Why?
Leukocyte Disorders
1
2015
1
0.040
Why?
Chi-Square Distribution
1
2016
356
0.040
Why?
Syncope
1
2015
21
0.040
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
18
0.040
Why?
Headache
1
2015
36
0.040
Why?
Lymphopenia
1
2015
40
0.040
Why?
Compassionate Use Trials
1
2014
2
0.040
Why?
Taxoids
1
2014
15
0.040
Why?
Lymphatic Metastasis
1
2014
53
0.040
Why?
Predictive Value of Tests
1
2017
674
0.040
Why?
Neoplasm Invasiveness
1
2014
160
0.040
Why?
Phenotype
1
2017
783
0.040
Why?
Combined Modality Therapy
1
2014
248
0.040
Why?
Genetic Predisposition to Disease
1
2017
429
0.040
Why?
Neoplasm Staging
1
2014
242
0.040
Why?
Multivariate Analysis
1
2016
717
0.040
Why?
Drug Therapy, Combination
1
2014
339
0.040
Why?
Alloys
1
2012
8
0.040
Why?
Constriction, Pathologic
1
2012
47
0.040
Why?
Endpoint Determination
1
2012
23
0.040
Why?
Angioplasty
1
2012
35
0.040
Why?
Recurrence
1
2012
385
0.030
Why?
Heart Function Tests
1
2011
20
0.030
Why?
Equipment Safety
1
2011
20
0.030
Why?
Fibrinolytic Agents
1
2012
150
0.030
Why?
Ventricular Remodeling
1
2011
32
0.030
Why?
Statistics, Nonparametric
1
2011
168
0.030
Why?
Equipment Design
1
2011
232
0.030
Why?
Platelet Aggregation Inhibitors
1
2012
223
0.030
Why?
Brain Ischemia
1
2012
196
0.030
Why?
Risk Factors
1
2016
2965
0.030
Why?
Prednisone
1
2008
64
0.030
Why?
Cohort Studies
1
2011
1358
0.020
Why?
Incidence
1
2009
768
0.020
Why?
Prospective Studies
1
2011
1612
0.020
Why?
Risk Assessment
1
2011
1047
0.020
Why?
Injections
1
2006
58
0.020
Why?
Thoracic Vertebrae
1
2006
25
0.020
Why?
Prevalence
1
2008
786
0.020
Why?
Pain, Intractable
1
2005
7
0.020
Why?
Radiography, Interventional
1
2006
58
0.020
Why?
Neoplasm Metastasis
1
2005
143
0.020
Why?
Preoperative Care
1
2005
112
0.020
Why?
Catheterization
1
2005
88
0.020
Why?
Radiography
1
2005
308
0.020
Why?
Pain
1
2005
217
0.020
Why?
Massari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_